These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 7024150)

  • 1. Patient compliance with dapsone administration in leprosy.
    Huikeshoven H
    Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):228-58. PubMed ID: 7024150
    [No Abstract]   [Full Text] [Related]  

  • 2. The story of sulfones in tropical medicine and dermatology.
    Wozel G
    Int J Dermatol; 1989; 28(1):17-21. PubMed ID: 2645226
    [No Abstract]   [Full Text] [Related]  

  • 3. A field trial among leprosy patients in Nigeria with depot injections of dapsone and monoacetyldapsone.
    Pieters FA; Woonink F; Zuidema J
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):10-20. PubMed ID: 3373080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple urine spot test for monitoring dapsone self-administration in leprosy treatment.
    Huikeshoven H
    Bull World Health Organ; 1986; 64(2):279-81. PubMed ID: 3488843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in leprosy control in the last 100 years.
    Bechelli LM
    Int J Lepr Other Mycobact Dis; 1973; 41(3):285-97. PubMed ID: 4591732
    [No Abstract]   [Full Text] [Related]  

  • 6. Operational study to monitor the regularity of dapsone intake by leprosy out-patients.
    Kumar A; Balakrishnan S
    Lepr India; 1983 Jul; 55(3):521-7. PubMed ID: 6656209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thirty years of leprosy control work--what next?
    Dharmendra
    Lepr India; 1980 Oct; 52(4):566-72. PubMed ID: 7464063
    [No Abstract]   [Full Text] [Related]  

  • 8. Association between regularity in dapsone (DDS) treatment and development of deformity.
    Radhakrishna S; Nair NG
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):425-34. PubMed ID: 3655458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring self administration of dapsone by patients.
    Balakrishnan S
    Lepr India; 1977 Jul; 49(3):364-71. PubMed ID: 592739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of self administration of dapsone in urine by out-patients attending field clinics.
    Balakrishnan S; Christian M
    Lepr India; 1980 Apr; 52(2):249-51. PubMed ID: 7453139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular injection of dapsone in therapy for leprosy: a new approach.
    Modderman ES; Huikeshoven H; Zuidema J; Leiker DL; Merkus FW
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):51-6. PubMed ID: 7061179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of the drugs with activity against M. leprae in mice.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1971; 39(2):340-8. PubMed ID: 4948080
    [No Abstract]   [Full Text] [Related]  

  • 13. Utilization of medical agencies and treatment compliance by urban (Madras) leprosy patients.
    Kumar A; Sivaprasad N; Anbalagan M; Thangavel N; Durgambal K
    Lepr India; 1983 Apr; 55(2):322-32. PubMed ID: 6632787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving patient compliance--a multicentre evaluation of the 'DDS tile test'.
    Naik SS; Vartak RR; Sequiera EB
    Indian J Lepr; 1994; 66(4):473-5. PubMed ID: 7714357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dapsone compliance in North-east India.
    Davies RA; Ng YY
    Lepr Rev; 1981 Mar; 52(1):51-3. PubMed ID: 7242217
    [No Abstract]   [Full Text] [Related]  

  • 16. Method for detecting sulfones in urine.
    Jaled MM; De Carli EI; Fariña MH; Gatti JC
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):560-1. PubMed ID: 3655470
    [No Abstract]   [Full Text] [Related]  

  • 17. Irregularity of Dapsone intake in infectious leprosy patients attending an urban treatment centre--its magnitude and causes.
    Naik SS
    Lepr India; 1978 Jan; 50(1):45-53. PubMed ID: 651317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ELISA inhibition technique for the demonstration of sulphones in body fluids. II. A new method to monitor leprosy patient compliance under field conditions.
    Huikeshoven H; de Wit M; Soeters A; Landheer J; Leiker DL
    Lepr Rev; 1981 Mar; 52(1):11-8. PubMed ID: 7017317
    [No Abstract]   [Full Text] [Related]  

  • 19. Dapsone compliance in an urban field project.
    Revankar CR; Naik SS; Ganapati R
    Lepr India; 1983 Jan; 55(1):117-21. PubMed ID: 6876753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tile test to monitor the self administration of dapsone by leprosy patients.
    Naik SS
    Lepr India; 1983 Oct; 55(4):665-9. PubMed ID: 6668922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.